Boundless Bio (BOLD) Capital Expenditures (2023 - 2026)
Boundless Bio (BOLD) reported Capital Expenditures of $38,000 for Q2 2026, down 20.8% from $48,000 a year earlier but up 375.0% from the prior quarter.
Powered by 
Analysis
Boundless Bio (BOLD) Capital Expenditures (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Boundless Bio's Capital Expenditures came in at $485,000, down 54.1% year-over-year; for FY2025, it was $546,000, down 78.5% from FY2024.
- By year, Capital Expenditures came in at $2.54 million in FY2024 (+300.6%) and $633,000 in FY2023.
- Five-year quarterly Capital Expenditures spans a low of $8,000 in Q1 2026 and a high of $1.5 million in Q2 2024.
- Year over year, Capital Expenditures has now declined in each of the last six quarters, with an average decline of 5.6% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q3 2024 (growth of 219.9%); the low point was Q3 2025 (a decline of 96.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8,000 (Q1 2026), $424,000 (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Boundless Bio | 58.66 Mn | 58.66 Mn | - | 38,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 424,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 466,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | 151,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | 86,000.00 |
API Access
Boundless Bio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BOLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BOLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BOLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();